Results 1 to 10 of about 58,392 (301)
Peptide receptor radionuclide therapy [PDF]
Best Practice & Research Clinical Gastroenterology, 2005 Peptide receptor radionuclide therapy is a new treatment modality for patients with inoperable or metastasised neuroendocrine gastroenteropancreatic tumours.
Esser, J.-P. (Jan-Paul) +5 more
core +7 more sources
Role of 18F-AlF-NOTATATE PET/CT in selecting pediatric neuroblastoma candidates for 177Lu-DOTATATE peptide receptor radionuclide therapy [PDF]
Frontiers in MedicineBackgroundNeuroblastoma is the most common extracranial solid tumor in children. Peptide receptor radionuclide therapy (PRRT) is a treatment modality with great potential, however, the predictive indicators for its efficacy remain unclear. The aim of the
Yuxuan Liu +7 more
doaj +2 more sources
Association of regional cerebral perfusion impairment with gait and balance performance in dizzy patients using brain perfusion SPECT: Voxel-based analysis of a pilot sample [PDF]
Asia Oceania Journal of Nuclear Medicine and Biology, 2021 Objective(s): The purpose of this study was to investigate regional cerebral blood flow (rCBF) reduction in patients with dizziness and perfusion-related clinical impairment using brain perfusion single photon emission tomography (SPECT).Methods: Thirty ...
Reza Nemati +7 more
doaj +1 more source
Radiographer, 2011 AbstractThis article follows the article An Introduction to Nuclear Medicine published in this issue of The Radiographer. Nuclear medicine is the injection, ingestion or inhalation of a radiopharmaceutical for the purpose of diagnosis or therapy. While the previous article focussed on the fundamental principles of diagnostic imaging, this paper focuses
JM Wheat, GM Currie, R Davidson, H Kiat
+4 more sources
Radiometals in Imaging and Therapy: Highlighting Two Decades of Research
Pharmaceuticals, 2023 The present article highlights the important progress made in the last two decades in the fields of molecular imaging and radionuclide therapy. Advancements in radiometal-based positron emission tomography, single photon emission computerized tomography,
Shalini Sharma, Mukesh K. Pandey
doaj +1 more source
Improvement of the approach to definition of patient release criteria after radionuclide therapy
Радиационная гигиена, 2023 Current patient release criteria established in NRB-99/2009 relate to four radionuclides used in Russia that period of the document preparation. These criteria were calculated only considering the radionuclide decay.
L. A. Chipiga +7 more
doaj +1 more source
Recent Advances in Hepatocellular Carcinoma Treatment with Radionuclides
Pharmaceuticals, 2022 As the third leading cause of cancer death worldwide, hepatocellular carcinoma (HCC) is characterized by late detection, difficult diagnosis and treatment, rapid progression, and poor prognosis.
Ruiqi Liu +4 more
doaj +1 more source
Targeted Radionuclide Therapy [PDF]
Cancers, 2011 Targeted radiotherapy is an evolving and promising modality of cancer treatment. The killing of cancer cells is achieved with the use of biological vectors and appropriate radionuclides. Among the many advantages of this approach are its selectiveness in delivering the radiation to the target, relatively less severe and infrequent side effects, and the
Ersahin, Devrim +2 more
openaire +2 more sources
A brief overview of targeted radionuclide therapy trials in 2022
Frontiers in Nuclear Medicine, 2023 There is a growing use of radionuclide therapy for the medical care of oncology patients, where radioactive pharmaceuticals are used to target and treat various cancer types.
Aidan Healy +3 more
doaj +1 more source
World Journal of Nuclear Medicine, 2020 Prostate-specific membrane antigen (PSMA) is a Type II transmembrane glycoprotein which is extremely overexpressed in prostate cancer epithelial cells. Recently, PSMA-targeted small molecule labeled with 68Ga and 99mTc allowed precise molecular imaging ...
Esmail Jafari +3 more
doaj +1 more source